The "Internet of Things" in particular continues to drive medtech M&As. It will be crucial to make the best possible use of the opportunities offered by digitalization and to be at the forefront of developments in terms of technology, safety and quality. M&As are an effective way for medical technology companies to overcome the current challenges facing the industry. "Even if there have been no mega deals recently, there is no room for boredom. There are numerous exciting OEM concentrations and consolidation measures in the second tier of medical technology manufacturers," says Peter Reinhardt, Editor-in-Chief of "DeviceMed".

You can find the entire article on the analysis here.
The article will also appear in the September issue of "DeviceMed" on September 11, 2018.
You can order a free press copy from: pressestelle@vogel.de
You can download the overview of medical technology M&As from the first half of 2018 here.

Practical knowledge for professionals in the medtech industry. DeviceMed is the leading German-language specialist medium for manufacturers of medical technology products and their suppliers with a clear focus on industrial practice and the industry's specific regulatory requirements. The online platform devicemed.de, newsletters, events and the moderation of the XING group "Medical Technology" with around 25,000 members complete the cross-media information offering of the community platform. The parent company Vogel Communications Group is one of the leading service providers for B2B communication in the German-speaking world. Its headquarters are in Würzburg. With four agencies in Berlin, the Group offers comprehensive communications expertise. The Group's services range from specialist media, corporate publishing, social media services, PR, trade fair services, networks and communities to market intelligence & insights and an in-house congress center.